Abb Schweiz Ag

Huawei Technologies Co., Limited

Merck Sharp + Dohme Corp.

Tongji University

Sap Se

Astrazeneca Ab

Abb Technology Ltd

Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.

Cspc Zhongqi Pharmaceuticall Technology (Shijiazhuang) Co., Ltd.

Cspc Zhongqi Pharmaceutical Technology Co., Ltd.

Tao Feng

Xiao Min Xu

Xiaodong Cao

Zhu Zhu

Kaiyuan Cao

Jian Li

Shuhui Chen

Ying Chu Wang

Hao Gu

Fengting Li

Hui Yu

Yikai Wang

Jingjing Zhou

Yongzhi Huang

Linlin Chen

Jie Li

Guoping Hu

Haiyang Yu

Hitesh Jayantilal Sanganee

Zhengxia Chen

Kangjian Wang

Jikui Sun

Michael Ries

Scott Trzaska

Wei Song

Jing Wu

Hiroki Wada

Xinguo Fu

Yun Ha

Alfred Lee

Jianhua Peng

Xingjie Wang

Songlin Li

Yangyang Xu

Mingli Huang

Peng Kong

Gongyao Ma

Zhen Shi

Qiu Li

Dan Zhang

Irina Kazakevich

Junjie Hu

Jonas Haulin

Deepak Bahl

Deyao Li

Yung-Chi Lee

William Anthony Marinaro, Jr

Eric Du

Jiran Ding

Kenny Zhang

Lily Xiao

Williams Liu

Chris Ge

Ziying Liao

Ken-Kangjian Wang

Stacy Rothenhoefer

Rongxin Huang

William Anthony Marinaro

Industrial robot

Embodiments of the present disclosure provide a robot. The robot arm link includes a first arm link; a hollow shaft extending along a first axis thereof and coupled to the first arm link; a first stage reduction assembly coupled to a power source of the robot; and a second stage reduction assembly comprising: an input coupled to an output of the first stage reduction assembly and adapted to rotate about a second axis offset from the first axis; and an output coaxially arranged on a periphery of the hollow shaft and adapted to engage with the input to cause a rotation of the first arm link via the hollow shaft.

Robot and assembly method thereof

Methods for managing a robot arm are disclosed. In one method, during a movement of the robot arm in an axis thereof, a signal collected by a sensor equipped at a frame of the robot arm is received. A change in strength of the received signal is detected, where the change is caused by an offset between a position of a reference mark equipped at the robot arm and a position of the sensor. An original point of the axis of the robot arm is determined based on the detected change. Further, robot systems, apparatuses, systems, and computer readable media for managing a robot arm in the robot systems are disclosed. The original point of the axis of the robot arm may be determined without a dedicated calibrating tool, and then the robot arm may be calibrated based on the original point accurately.

Method and apparatus for managing robot arm

A ring seal and a robot. The ring seal includes an outer circumferential wall and an annular portion. The outer circumferential wall extends in an axial direction of the ring seal. The annular portion extends from a side of the outer circumferential wall toward an interior of the outer circumferential wall in a radial direction of the ring seal. As viewed in a cross section taken along the radial direction, the annular portion and the outer circumferential wall form an L shape.

Ring seal and a robot

Embodiments of the present disclosure provide a planetary gearbox. The planetary gearbox includes a housing extending along a first axis; a first coupling member arranged on an inner circumference of the housing; an input component operable to rotate about the first axis; at least one intermediate component, each intermediate component comprising a second coupling member and adapted to be driven by the input component to rotate about a second axis offset from the first axis with the second coupling member engaging with the first coupling member; and an output component coupled to the at least one intermediate component and operable to rotate about the first axis with rotation of the at least one intermediate component, wherein at least one of the first coupling member and the second coupling member comprises a synchronous belt.

Planetary gearbox, assembly method thereof, associated robot joint and robot

A copper integrated electrode with a convertible oxidation state, a preparation method and an application method are provided. The preparation process is based on an electrochemically induced self-growth method. Copper foam is used as a precursor, soaked in a graphene oxide solution, dried, calcined at high temperature and annealed, and then treated with an alkali solution to obtain the copper integrated electrode with the convertible oxidation state. The working electrode prepared by the nano-catalytic material of the present invention has good denitrification performance in the environmental field, which can achieve nearly 100% nitrate removal rate, nearly 100% nitrogen selectivity and long-term stability. These properties are due to the prepared working electrode having an oxidizable copper (I, II/0, I), oxygen vacancy (O) and a one-dimensional nanowire structure. The structure can regulate the adsorption and reduction of intermediate products, resulting in nearly 100% nitrate removal rate and nearly 100% nitrogen selectivity.

Copper integrated electrode with convertible oxidation state and preparation method and application method thereof

A ball screw spline assembly includes a ball screw spline including a first nut including a first mounting surface adapted to receive a first fastening element; a second nut including a second mounting surface adapted to receive a second fastening element; and a shaft passing through the first nut and the second nut; the housing including a first portion and a second portion, the first portion extends in a direction substantially parallel to the shaft, and the second portion extends in a direction substantially perpendicular to the shaft; a connecting plate coupling the second nut to the first portion, the first nut is installed to the second portion; the first mounting surface and the second mounting surface are located within a space defined by the first portion, the second portion and the connecting plate, such that the ball screw spline is integrally installable to the housing.

Ball screw spline assembly and related method

A method for assembling and synthesizing CuO particle-supported porous CuBTC includes the following steps of: 1) dissolving polyvinylpyrrolidone (PVP) in ethanol solution to obtain a PVP-ethanol solution; 2) dissolving copper salt in distilled water, and mixing with trimesic acid, salicylic acid, and the PVP-ethanol solution obtained in step 1) under stirring; and 3) conducting a hydrothermal reaction on the mixed solution obtained in step 2) at 120&#xb0; C. to obtain CuO particle-supported porous CuBTC. The new method introduces salicylic acid during the synthesis of CuBTC. The salicylic acid, as a ligand precursor, forms a porous CuBTC material through the unsaturated coordination of a ligand under the catalysis of Cu ion. The resulting porous CuBTC supported with ultrafine CuO nanoparticles can adsorb high-energy molecules and exhibit excellent crystallinity, porosity, and stability.

Method for assembling and synthesizing CuO particle-supported porous CuBTC

An energy efficiency control method and apparatus are provided. The method, implemented by a communications device comprising a primary power supply, a secondary power supply, and a control apparatus, includes: obtaining a current load rate of the primary power supply and a load power of the secondary power supply; determining, based on the obtained current load rate and the load power, a target output voltage of the primary power supply and a target input voltage of the secondary power supply that satisfy an energy efficiency requirement of the communications device, wherein energy efficiency of the communications device is related to the energy efficiency of the primary power supply and the energy efficiency of the secondary power supply; and controlling the primary power supply to output the target output voltage, and controlling an input voltage of the secondary power supply to be the target input voltage.

Energy efficiency control method, control apparatus, and communications device

Provided is a FGFR inhibitor, designating a compound represented by formula (I) or a pharmaceutically acceptable salt thereof. Also provided is the application of a drug for treating solid tumors, such as FGFR related diseases. 

Substituted pyrrolo[2,1-f][1,2,4]triazines as FGFR inhibitors

Disclosed are an FGFR inhibitor and the use thereof in the preparation of a drug for treating FGFR-related diseases. In particular, disclosed are a compound as shown in formula (I) and a pharmaceutically acceptable salt thereof. 

Disclosed is a wiring unit having a main portion of a flexible printed circuit (FPC) board therein. Said rotary joint further comprises a protective unit fixed to said wiring unit, in which an end portion of said FPC board is connected to a group of cables. Also disclosed is a robot comprising said rotary joint. Compared with the existing prior arts, the proposed solutions prevent the damage of FPC during assembly and/or disassembly of robots, while not losing compactness.

Rotary joint of a robot and the robot including the same

The invention includes a granular composition comprising the active ingredient (S)&#x2014;N-(3-(6-isopropoxypyridin-3-yl)-1H-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2H)-yl)-2-oxoethyl)-3-(methylthio)pyrrolidine-3-carboxamide, wherein a total amount of active ingredient comprises by weight % about 60-90% (S)&#x2014;N-(3-(6-isopro-poxypyridin-3-yl)-1H-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)-3,6-di-hydropyridin-1(2H)-yl)-2-oxoethyl)-3-(methylthio)pyrrolidine-3-carboxamide Form 1 HCl, about 10-30% (S)&#x2014;N-(3-(6-isopropoxypyridin-3-yl)-1H-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2H)-yl)-2-oxoethyl)-3-(methylthio)pyrrolidine-3-carboxamide amorphous HCl, and about 0-5% (S)&#x2014;N-(3-(6-isopropoxypyridin-3-yl)-1H-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2H)-yl)-2-oxoethyl)-3-(methylthio)pyrrolidine-3-carboxamide amorphous free base.

(S)-N-(3-(6-isopropoxypyridin-3-yl)-1H-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2H)-yl)-2-oxoethyl)-3-(methylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparations

The present invention provides a novel synthesis of verubecestat, and two novel crystalline forms of verubecestat, as well as pharmaceutically acceptable compositions thereof, each of which may be useful in treating, preventing, ameliorating, and/or delaying the onset of an A&#x3b2; pathology and/or a symptom or symptoms thereof. Non-limiting examples of such A&#x3b2; pathologies, including Alzheimer's disease, are disclosed herein.

Crystalline forms of a BACE inhibitor, compositions, and their use

Growing community of inventors

Shanghai, China

Tao Feng